Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
about
Hallmarks of glycosylation in cancerCancer metabolism and elevated O-GlcNAc in oncogenic signalingDiscovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methodsIncreasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L miceQuantitative proteomic analysis of histone modificationsTandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.A novel two-stage tandem mass spectrometry approach and scoring scheme for the identification of O-GlcNAc modified peptides.O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteinsCharacterization of the specificity of O-GlcNAc reactive antibodies under conditions of starvation and stress.O-GlcNAc signaling in the cardiovascular system.Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags.Intracellular protein glycosylation modulates insulin mediated lifespan in C.elegans.Incorporation of unnatural sugars for the identification of glycoproteins.Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic miceThe E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc.Proteomic approaches for site-specific O-GlcNAcylation analysis.Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes.Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.The dynamic stress-induced "O-GlcNAc-ome" highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways.Synthetic Receptors for the High-Affinity Recognition of O-GlcNAc Derivatives.Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal LigationMultiple proteins with essential mitochondrial functions have glycosylated isoformsDynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.O-GlcNAc and the cardiovascular system.Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation.Carbohydrate chemistry in drug discovery.Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination.Protein O-GlcNAcylation in diabetes and diabetic complications.Hepatic glucose sensing and integrative pathways in the liver.Interaction modes and approaches to glycopeptide and glycoprotein enrichment.Glycosylation of the nuclear pore.O-GlcNAc profiling: from proteins to proteomes.Detection and identification of O-GlcNAcylated proteins by proteomic approaches.Altered expression of O-GlcNAc-modified proteins in a mouse model whose glycemic status is controlled by a low carbohydrate ketogenic diet.
P2860
Q26752363-A131C8D6-6DD6-4771-870E-C4A020F3C3D4Q26859087-38C7E41D-4940-4B47-A164-D124F640B66EQ28533987-CBEE66F0-E87C-42FF-8F2B-B2721DB7D0D2Q28537913-113FC06C-7771-4807-914D-9A863D021F79Q30375585-ADF095AD-ABA4-4133-B347-0CC8CD68B31AQ30424053-710A46C1-1E3C-4EE0-B3A9-D1F652ED3A0DQ33676228-26709C10-FFE1-408E-82FC-46D62FF55537Q33683197-BB4FD9E8-B3A5-4A3B-87FE-310C3EFD54EAQ33864754-F0670FEB-C16A-4DAF-8D15-A49DEC281183Q33907013-1A7CAA7E-2284-41F7-8D3D-582521CB1A84Q33964124-4A170515-BC26-4D51-BEBB-5452309C0860Q34056858-E0F3BFC4-4686-4B81-87F2-8554D577B83EQ34075637-6945F772-4481-4A92-A757-0FA3707A9B56Q34361218-EC21C61F-76B2-47AC-995B-127A1F0BFFC6Q34496517-50EE5615-46D6-45D1-B971-64052C631124Q34512181-77B962B9-F5CD-4B1C-B873-1069F00F353EQ34538240-99E13AAC-C525-4BAC-8DBA-75AF6888B56EQ34763872-15A02E9B-D28C-496A-BC11-A29249B73E45Q35002612-6705409F-CD7A-45D1-B701-4B851C3693B7Q35310496-8EA56BCB-0E1C-4F5C-8F09-FBD72978D3F2Q35800918-79C181F0-8CD9-4C86-A9E7-987798962C8DQ35898104-E851E609-0D42-47D3-8A45-D428F74486B8Q35907638-06A2F6FD-140D-4B35-B0CC-BBE7611B56EFQ35939748-F2ECD4A1-154E-4A7F-8ECF-C5C8B22AFA9FQ35994096-FD573C7F-F2F3-412E-85D6-85001D08ED9EQ36566645-85C586FD-C80A-4317-BF21-9012E767652EQ36677483-AF29519D-B67D-49D9-82D8-623632517A62Q37099485-0C0E2B5D-2200-4BE8-A77C-9E8455C31797Q37619691-974C0449-55AA-432A-B917-90570EF9D7DEQ37736782-7F2E55FB-DF4C-4144-93F4-42F3240F4A17Q37853437-8809F4C8-7A85-43DD-B5F9-2ADDC3D7B2DFQ37924015-69259D9C-0867-4C42-9F66-47EB4074CF07Q38119185-48010ACE-1394-4433-901B-11264A13DA0CQ38132916-93C3E3CD-8F54-4841-9370-6D29AD9C99F6Q38160330-126968DC-D4DF-45AB-9EEC-258E22D448B5Q38171227-18442640-7707-440B-BAA5-113FFB8E6870Q38178370-FBE9F9D3-C08F-48F6-B01B-4C5B57701794Q38193224-0F70F976-6AFB-4FC4-8648-4A5048C3774BQ38272067-954F311F-1491-4F1E-AEE1-CBED649B23DAQ38314633-759F4A5A-0BBB-4BCC-B40C-D2182AB65F20
P2860
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@ast
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@en
type
label
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@ast
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@en
prefLabel
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@ast
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@en
P2093
P2860
P50
P356
P1476
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.
@en
P2093
Chin Fen Teo
John C Chatham
Lance Wells
Laszlo G Nöt
Sampat Ingale
P2860
P2888
P304
P356
10.1038/NCHEMBIO.338
P577
2010-03-21T00:00:00Z